Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial endpoint data. Analysts see Clario's offerings as highly complementary to PPD, the contract research organization that Thermo Fisher acquired in 2021.
Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial endpoint data. Analysts see Clario's offerings as highly complementary to PPD, the contract research organization that Thermo Fisher acquired in 2021.
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
David Oakley, AdventHealth's chief digital officer, said AI could transform healthcare personalization — moving from broad population segments to individualized "segments of one." In the future, providers could use connected data platforms to better understand patients' clinical, social and emotional needs, which has potential to strengthen both trust and engagement, he stated.
No comments